#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Osteogenesis imperfecta Transient ischaemic attack Acute myeloid leukaemia recurrent Neuroendocrine tumour Central nervous system lymphoma Waldenstrom's macroglobulinaemia recurrent Pustular psoriasis Neovascular age-related macular degeneration Gastrointestinal stromal tumour Kidney transplant rejection Haemophilia A with anti factor VIII Immunodeficiency congenital Cold type haemolytic anaemia Chronic cutaneous lupus erythematosus Tuberous sclerosis complex More trials…

    Learn about Rare Diseases

    Crigler-Najjar syndrome Hyperoxaluria – Trials in Disease Cholangitis sclerosing Familial haemophagocytic lymphohistiocytosis – Life with Disease Osteosarcoma recurrent – Diagnostics Hereditary motor and sensory neuropathy Sjogren’s syndrome – Life with Disease Marginal zone lymphoma refractory – Life with Disease Combined immunodeficiency – Trials in Disease Primary mediastinal large B-cell lymphoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ATOVAQUONE Fusidic Acid Riboflavin Sodium Phosphate Abc-24F-116 Amphotericine B, Liposome Pbf-999 ELTANEXOR Pioglitazone Amylase Palbociclib Nms-03592088 Sotrovimab BUMETANIDE Protamine Sulfate Immunostimulants Anhydrous Docetaxel Amiloride NADOFARAGENE FIRADENOVEC GSK5733584 Belantamab Mafodotin More therapies…

    Learn about Your Condition

    Rasmussen encephalitis Crohn's disease Glioblastoma multiforme Ewing's sarcoma Usher's syndrome Type V hyperlipidaemia Polymyalgia rheumatica Metastatic malignant melanoma Venous thrombosis limb Netherton's syndrome Neoplasm Type 1 diabetes mellitus Hypoxia Persistent depressive disorder Endocarditis enterococcal More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Monogenic diabetes

  • Increasing the dose of glimepiride for patients with HNF1A-MODY or HNF4A-MODY diabetes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Monogenic diabetes
    Investigated Drugs:
    • Glimepiride
    Denmark

  • Study on the Effects of Empagliflozin on Blood Sugar Levels in Patients with HNF1A-MODY Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Monogenic diabetes
    Investigated Drugs:
    • Empagliflozin
    Denmark

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!